feed,title,long_url,short_url
Benzinga,Biosight to Present Updated Clinical Data from Ongoing Phase 2b Study of Aspacytarabine (BST-236) at the 2020 ASH Annual Meeting,https://www.benzinga.com/pressreleases/20/11/g18229705/biosight-to-present-updated-clinical-data-from-ongoing-phase-2b-study-of-aspacytarabine-bst-236-at,https://j.mp/3esb58S
